Resolution of COVID-19 induced anosmia following treatment with ST266

BACKGROUND: Persistent anosmia following COVID-19 disease affects a significant subset of patients. Symptoms of this olfactory dysfunction negatively impact patient quality of life, and effective treatments are lacking; therefore, novel therapies that restore the ability to smell have tremendous cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhutani, Devica L., Ross, Ahmara G., Lehman, Amanda Y., Shindler, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444303/
https://www.ncbi.nlm.nih.gov/pubmed/36090590
http://dx.doi.org/10.1016/j.xocr.2022.100475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444303/
https://www.ncbi.nlm.nih.gov/pubmed/36090590
http://dx.doi.org/10.1016/j.xocr.2022.100475

Ejemplares similares